NIH-funded research NIH-funded research

Creating antibodies to study mosquito immune responses to malaria

Official title: Epitope-directed monoclonal antibody production for mosquito immune cells (for malaria)

Funded at Luna Labs USA, LLC · NIH-10933280 · Data updated 2026-11-12

This study is working on creating special antibodies that can help scientists learn more about how mosquitoes fight off diseases like malaria, which could lead to better ways to control these diseases that affect people.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionLuna Labs USA, LLC
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$599,993
NIH project number75N93023C00037-0-9999-1
Project IDNIH-10933280 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living in areas where malaria is prevalent and who may benefit from advancements in vector-borne disease management.

Less likely to help

Patients who do not live in malaria-endemic regions or those who are not affected by vector-borne diseases may not receive direct benefits from this research.

What this research studies

This research focuses on developing monoclonal antibodies that can identify and characterize immune cells in mosquitoes. By targeting specific proteins in mosquito hemocytes, the project aims to understand how these insects respond to pathogens like malaria. The antibodies will be validated through various immunoassays and surface plasmon resonance techniques, which will help in studying the immune responses that mosquitoes have against diseases they transmit to humans. This work could provide valuable insights into vector-borne diseases and improve strategies for disease control.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and control of malaria and other diseases transmitted by mosquitoes.

How similar studies have gone: Previous research has shown promise in using monoclonal antibodies for studying immune responses in various contexts, suggesting that this approach could yield valuable results.

Where this research is happening

  • Luna Labs USA, LLC
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Yu, Yang — Luna Labs USA, LLC
  • Study coordinator: Yu, Yang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.